{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04351932",
      "OrgStudyIdInfo": {
        "OrgStudyId": "UCSantiagodeGuayaquil001"
      },
      "Organization": {
        "OrgFullName": "Universidad Catolica Santiago de Guayaquil",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis",
      "OfficialTitle": "Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2020",
      "OverallStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "June 7, 2020",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 7, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 7, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "May 4, 2019",
      "StudyFirstSubmitQCDate": "April 16, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 17, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "April 16, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 17, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Dr. Carlos Chiriboga Accini",
        "ResponsiblePartyInvestigatorTitle": "Research Professor. Orthopaedic Staff. Omnihospital.",
        "ResponsiblePartyInvestigatorAffiliation": "Universidad Catolica Santiago de Guayaquil"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Universidad Catolica Santiago de Guayaquil",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Maastricht University Medical Center",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No",
      "IsUSExport": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Mesenchymal stem cells (MSC) are stromal cells that have the ability to self-renew and also exhibit multilineage differentiation. MSCs can be isolated from a variety of tissues, such as umbilical cord, bone marrow, and adipose tissue. The multipotent properties of MSCs make them a promising option for the treatment of osteoarthritis (OA).\n\nBone marrow mesenchymal stem cells (BM-MSC) and adipose derived mesenchymal stem cells (AD-MSC) have been used separately to treat OA. The aim of the present study will be to compare in a randomized non blind controlled clinical trial 3 types of intra-articular injections containing MSC populations obtained from two clinically relevant sources: BM-MSC, AD-MSC and a combination of both BM-MSC and AD-MSC.",
      "DetailedDescription": "The aim of the present study will be to compare 3 types of intra-articular injections of MSC populations obtained from two clinically relevant sources: injections containing BM-MSC or AD-MSC or a combination of both BM-MSC,and AD-MSC in a randomized non blind clinical trial.\n\nTo assess the efficacy and safety of 3 kind of MSC injections in relation to pain, function and quality of life in patients with knee OA.\n\nA total of 54 patients with the diagnosis of knee OA grade II and III will be recruited to receive a single intra-articular injection of MSC: Group 1 (n 18 patients) will receive BM-MSC, Group 3 (n 18 patients) will receive AD-MSC. Group 3 (18 patients) will receive a combination of BM-MSC and AD-MSC.\n\nA randomized non blind clinical trial with active control. For this purpose, the random number generator is 54, found on the RANDOM.ORG ® website (available at https://www.random.org/integers/)"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteo Arthritis Knee"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal stem cell"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "A total of 54 patients with the diagnosis of knee OA grade II and III will be recruited to receive a single intra-articular injection of MSC: Group 1 (n 18 patients) will receive BM-MSC, Group 2 (n 18 patients) will receive AD-MSC. Group 3 (18 patients) will receive a combination of BM-MSC and AD-MSC.",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)",
          "DesignMaskingDescription": "A randomized non blind clinical trial with active control. For this purpose, the random number generator, found on the RANDOM.ORG ® website (available at https://www.random.org/integers/)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "54",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "bone marrow mesenchymal stem cell",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Bone marrow mesenchymal stem cells 10 cc by intra articular injection once",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: bone marrow mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "adipose mesenchymal stem cells",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Stromal vascular factor from adipose mesenchymal stem cells 10 cc by intra articular injection once",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Adipose Mesenchymal stem cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Bone marrow and Adipose mesenchymal stem cells",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Bone marrow and Stromal vascular factor from adipose mesenchymal stem cells 5 cc each one, by intra articular injection once.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: bone marrow & adipose mesenchymal stem cells injection"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "bone marrow mesenchymal stem cells",
            "InterventionDescription": "intrarticular bone marrow mesenchymal stem cells injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "bone marrow mesenchymal stem cell"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Adipose Mesenchymal stem cells",
            "InterventionDescription": "intrarticular adipose mesenchymal stem cells injection",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "adipose mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "bone marrow & adipose mesenchymal stem cells injection",
            "InterventionDescription": "intrarticular bone marrow and adipose stem cells injection.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Bone marrow and Adipose mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "knee pain assessed by Visual Analogue Scale.",
            "PrimaryOutcomeDescription": "psychometric response scale which used in questionnaires. It is a measurement instrument for subjective characteristics of pain . Score from O to 10. O indicate no pain, and 10 indicate the worst pain.",
            "PrimaryOutcomeTimeFrame": "12 months"
          },
          {
            "PrimaryOutcomeMeasure": "knee function assessed by WOMAC (Wester Ontario McMaster Osteoarthritis Index). quosteionary.",
            "PrimaryOutcomeDescription": "The Index contains 24 questions five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Individual question responses are assigned a score of between 0 (extreme) and 4 (None). Individual question scores are then summed to form a raw score ranging from 0 (worst) to 96 (best). Finally, raw scores are normalized by multiplying each score by 100/96. This produces a reported WOMAC Score of between 0 (worst) to 100 (best).",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Quantitative T2-Mapping Evaluation of Changes in Cartilage Matrix",
            "SecondaryOutcomeDescription": "MRI T2 mapping of the cartilage is a non-invasive functional imaging technique delivering cartography of the T2 relaxation time of the cartilage without any contrast injection. It is sensitive to tissue anisotropy, and provides compositional information on the cartilage collagen network, water content and proteoglycans concentration.",
            "SecondaryOutcomeTimeFrame": "6 months after procedure"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients aged 18 to 70 years, with grade II and III knee OA, according to the Ahlbäck classification will be included.\nMinimal VAS pain score of 4.\nChronic knee pain of mechanical origin.\nAll patients who sign a specially prepared informed consent for this clinical trial.\n\nExclusion Criteria:\n\nVarus or valgus knee mal alignment superior to 10°.\nOA grade IV according Ahlbäck classification.\nBone marrow cancer like lymphoma.\nSevere anemia.\nActive infections.\nPregnant patients.\nInmune diseases such as Rheumatoid arthritis, gout or pseudogout arthritis, psoriasis.\nBone diseases such as Kahler and Paget.\nCorticoesteroid and hyaluronic injections within the last 3 months.\nKnee surgery in the last 6 months.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Carlos A Chiriboga, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "593 9 9995 4148",
            "CentralContactEMail": "drcarloschiriboga@gmail.com"
          },
          {
            "CentralContactName": "Peter A Chedraui, Phd",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "593 9 9942 4629",
            "CentralContactEMail": "peter.chedraui@cu.ucsg.edu.ec"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Carlos A Chiriboga, MD",
            "OverallOfficialAffiliation": "Universidad Católica Santiago de Guayaquil",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Omnihospital",
            "LocationCity": "Guayaquil",
            "LocationState": "Guayas",
            "LocationZip": "9018",
            "LocationCountry": "Ecuador",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Carlos Chiriboga",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "593 9 99954148",
                  "LocationContactEMail": "drcarloschiriboga@gmail.com"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "16263424",
            "ReferenceType": "result",
            "ReferenceCitation": "Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005 Nov;33(11):1402-16."
          },
          {
            "ReferencePMID": "11869080",
            "ReferenceType": "result",
            "ReferenceCitation": "Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002 Mar;10(3):199-206."
          },
          {
            "ReferencePMID": "25944079",
            "ReferenceType": "result",
            "ReferenceCitation": "Xia P, Wang X, Lin Q, Li X. Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop. 2015 Dec;39(12):2363-72. doi: 10.1007/s00264-015-2785-8. Epub 2015 May 6. Review."
          },
          {
            "ReferencePMID": "20603892",
            "ReferenceType": "result",
            "ReferenceCitation": "Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M, Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K, Ohgushi H. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011 Feb;5(2):146-50. doi: 10.1002/term.299."
          },
          {
            "ReferencePMID": "24449146",
            "ReferenceType": "result",
            "ReferenceCitation": "Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS, Shin IS, Ra JC, Oh S, Yoon KS. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014 May;32(5):1254-66. doi: 10.1002/stem.1634. Erratum in: Stem Cells. 2017 Jun;35(6):1651-1652."
          },
          {
            "ReferencePMID": "23831631",
            "ReferenceType": "result",
            "ReferenceCitation": "Peeters CM, Leijs MJ, Reijman M, van Osch GJ, Bos PK. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage. 2013 Oct;21(10):1465-73. doi: 10.1016/j.joca.2013.06.025. Epub 2013 Jul 4. Review."
          },
          {
            "ReferencePMID": "27229856",
            "ReferenceType": "result",
            "ReferenceCitation": "Freitag J, Bates D, Boyd R, Shah K, Barnard A, Huguenin L, Tenen A. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review. BMC Musculoskelet Disord. 2016 May 26;17:230. doi: 10.1186/s12891-016-1085-9. Review."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes",
      "IPDSharingDescription": "all IPD that underlie results in a publication",
      "IPDSharingInfoTypeList": {
        "IPDSharingInfoType": [
          "Study Protocol",
          "Statistical Analysis Plan (SAP)",
          "Informed Consent Form (ICF)",
          "Clinical Study Report (CSR)"
        ]
      },
      "IPDSharingTimeFrame": "JUNE 2021 TO SEPTEMBER 2021",
      "IPDSharingAccessCriteria": "drcarloschiriboga@gmail.com"
    }
  },
  "DocumentSection": {
    "LargeDocumentModule": {
      "LargeDocList": {
        "LargeDoc": [
          {
            "LargeDocTypeAbbrev": "Prot_SAP",
            "LargeDocHasProtocol": "Yes",
            "LargeDocHasSAP": "Yes",
            "LargeDocHasICF": "No",
            "LargeDocLabel": "Study Protocol and Statistical Analysis Plan",
            "LargeDocDate": "March 3, 2020",
            "LargeDocUploadDate": "04/15/2020 13:23",
            "LargeDocFilename": "Prot_SAP_000.pdf"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteo Arthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Osteo Arthritis Knee",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}